LIU Tianxiang,ZHAO Qian,HAO Jing,et al.YAN Huimin's Experience in Staged Treatment of Pediatric IgA Vasculitis[J].Journal of Traditional Chinese Medicine,2025,66(12):1212-1216.
LIU Tianxiang,ZHAO Qian,HAO Jing,et al.YAN Huimin's Experience in Staged Treatment of Pediatric IgA Vasculitis[J].Journal of Traditional Chinese Medicine,2025,66(12):1212-1216.DOI: 10.13288/j.11-2166/r.2025.12.004.
YAN Huimin's Experience in Staged Treatment of Pediatric IgA Vasculitis
This paper summarizes Professor YAN Huimin's clinical experience in the staged treatment of pediatric IgA vasculitis. It is believed that the pathogenesis in the acute stage is characterized by fire and heat entering the blood and damaging the collaterals, and the treatment should focus on clearing heat and stopping bleeding, using the self-formulated
Qingzi Liangxue Formulation
(青紫凉血方). In the remission stage, the pathogenesis is
qi
rebellion leading to blood extravasation. The treatment principle is to regulate
qi
and stabilize blood, using the self-formulated
Heqi Ningxue Formulation
(和气宁血方). During the protracted stage, the pathogenesis is latent pathogenic factors due to
yin
deficiency, and the treatment should aim to nourish the collaterals and strengthen the root, with the self-formulated
Yangluo Guben Formulation
(养络固本方). Meanwhile, the method of promoting blood stasis resolution is
consistently applied throughout the entire treatment process.
关键词
Keywords
references
XU L , LI Y , WU X . IgA vasculitis update: epidemiology, pathogenesis, and biomarkers [J]. Front Immunol , 2022 , 13 : 921864 . doi: 10.3389/fimmu.2022.921864 http://dx.doi.org/10.3389/fimmu.2022.921864 .
ONI L , PLATT C , MARLAIS M , et al . National recommendations for the management of children and young people with IgA vasculitis: a best available evidence, group agreement-based approach [J]. Arch Dis Child , 2024 , 110 ( 1 ): 67 - 76 .
RONKAINEN J , KOSKIMIES O , ALA-HOUHALA M , et al . Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial [J]. J Pediatr , 2006 , 149 ( 2 ): 241 - 247 .
HAHN D , HODSON EM , WILLIS NS , et al . Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP) [J]. Cochrane Database Syst Rev , 2015 , 2015 ( 8 ): CD005128 . doi: 10.1002/14651858. CD005128.pub3 http://dx.doi.org/10.1002/14651858.CD005128.pub3 .
SRIRANGAN P , SHYAM M , RADHAKRISHNAN V , et al . NLRP3 as a therapeutic target in cyclophosphamide-associated toxicities [J]. Mol Biol Rep , 2025 , 52 ( 1 ): 364 .
Traditional Chinese Medicine Syndromes and Pathogenesis Characteristics of 14809 Children with Henoch-Schonlein Purpura in Henan Province:A Retrospective Analysis
Clinical Experience of Professor CUI Yinglin in Treating Pediatric Mitochondrial Encephalomyopathy Based on the Original Qi Theory
Imaging Measurement of the Safe Distances of Acupuncture at Fengfu (GV 16) in Children Aged 4 to 8 Based on CT Three-Dimensional Reconstruction
Exploring the Pathogenesis and Treatment of Adenoidal Hypertrophy in Children Based on the "Kenang (窠囊)" Theory
Differentiation and Treatment of Attention Deficit Hyperactivity Disorder from the Perspective of Deficiency,Stasis and Stagnation
Related Author
GAO Min
DING Ying
REN Xianqing
ZHANG Xia
SONG Chundong
HAN Shanshan
ZHAI Wensheng
WU Ruihong
Related Institution
The First Affiliated Hospital of Henan University of Chinese Medicine
The Second Clinical Medical College,Henan University of Chinese Medicine
Henan Provincial Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Henan University of Chinese Medicine
School of Basic Medicine,Inner Mongolia Medical University
School of Chinese Medicine,Beijing University of Chinese Medicine